JP Morgan Downgrades CareFusion To Neutral

Analysts at JP Morgan downgraded CareFusion

from Overweight to Neutral. The price target for CareFusion has been raised from $48 to $59. CareFusion shares have climbed 54.51% over the past 52 weeks, while the S&P 500 index has gained 18.69% in the same period. CareFusion's shares jumped 22.92% to close at $56.75 yesterday.